1- AXON $23: Long Term short.. I would wait for 25 dollars.. This is going to be a long term downward move. But it is a biotech. My target is below 10.

2- TXMD $5.44: Very risky.. But their clinical trials are not convincing. This will be below 3 bucks when the results are announced which I think is expected later Sept.

3- OCUL $6.44: Subpar and manipulated clinical data. It will be below 5..

4- CBAY 6.83. I did recommend it as a short last week at high 7's and already down.. I am hoping for a rebound above 7 and I would short. I played it wrong last time.. MM got me out early..